Insulin analogs and methods of use thereof

Insulin (INS) analogs are disclosed that include modifications compared to native human INS that increase half-life, maintain selectivity for insulin receptor (IR), and provide in vitro and in vivo stability to improve druggability and reduce immunogenicity. Also disclosed are pharmaceutical composi...

Full description

Saved in:
Bibliographic Details
Main Authors VERDINO PAOLO, LEE, STEPHEN, L, BERNARD, MICHAEL, J., SR
Format Patent
LanguageChinese
English
Published 11.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Insulin (INS) analogs are disclosed that include modifications compared to native human INS that increase half-life, maintain selectivity for insulin receptor (IR), and provide in vitro and in vivo stability to improve druggability and reduce immunogenicity. Also disclosed are pharmaceutical compositions comprising one or more INS analogs described herein in a pharmaceutically acceptable carrier. Also disclosed are methods of making and using the INS analogs, particularly for the treatment of metabolic conditions, diseases, or disorders, particularly for the treatment of diseases such as diabetes and obesity. 公开了胰岛素(INS)类似物,其包括与天然人INS相比的修饰,所述修饰增加半衰期、维持对胰岛素受体(IR)的选择性和提供体外和体内稳定性以改善成药性和降低免疫原性。还公开了药物组合物,其包括在药学上可接受的载体中的一种或多种本文所述的INS类似物。还公开了制备和使用INS类似物的方法,特别是用于治疗代谢病症、疾病或障碍,尤其是治疗疾病诸如糖尿病和肥胖。
AbstractList Insulin (INS) analogs are disclosed that include modifications compared to native human INS that increase half-life, maintain selectivity for insulin receptor (IR), and provide in vitro and in vivo stability to improve druggability and reduce immunogenicity. Also disclosed are pharmaceutical compositions comprising one or more INS analogs described herein in a pharmaceutically acceptable carrier. Also disclosed are methods of making and using the INS analogs, particularly for the treatment of metabolic conditions, diseases, or disorders, particularly for the treatment of diseases such as diabetes and obesity. 公开了胰岛素(INS)类似物,其包括与天然人INS相比的修饰,所述修饰增加半衰期、维持对胰岛素受体(IR)的选择性和提供体外和体内稳定性以改善成药性和降低免疫原性。还公开了药物组合物,其包括在药学上可接受的载体中的一种或多种本文所述的INS类似物。还公开了制备和使用INS类似物的方法,特别是用于治疗代谢病症、疾病或障碍,尤其是治疗疾病诸如糖尿病和肥胖。
Author BERNARD, MICHAEL, J., SR
LEE, STEPHEN, L
VERDINO PAOLO
Author_xml – fullname: VERDINO PAOLO
– fullname: LEE, STEPHEN, L
– fullname: BERNARD, MICHAEL, J., SR
BookMark eNrjYmDJy89L5WTQ8swrLs3JzFNIzEvMyU8vBtIpCrmpJRn5KcUK-WkKpcWpCiUZqUWp-Wk8DKxpiTnFqbxQmptB0c01xNlDN7UgPz61uCAxOTUvtSTe2c_Q0MTQ3MTYxMLRmBg1AAZVKo4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 胰岛素类似物及其使用方法
ExternalDocumentID CN114174348A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN114174348A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:57:07 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN114174348A3
Notes Application Number: CN202080054344
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220311&DB=EPODOC&CC=CN&NR=114174348A
ParticipantIDs epo_espacenet_CN114174348A
PublicationCentury 2000
PublicationDate 20220311
PublicationDateYYYYMMDD 2022-03-11
PublicationDate_xml – month: 03
  year: 2022
  text: 20220311
  day: 11
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies ILERY COMPANY
RelatedCompanies_xml – name: ILERY COMPANY
Score 3.4953156
Snippet Insulin (INS) analogs are disclosed that include modifications compared to native human INS that increase half-life, maintain selectivity for insulin receptor...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Insulin analogs and methods of use thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220311&DB=EPODOC&locale=&CC=CN&NR=114174348A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMQSWeskGSQa6hskm5romxokpupap5ma6ySmmFmnmSYYGaeA7lnz9zDxCTbwiTCOYGLJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3bGQETKOGai5Otq4B_i7-zmrOzrbOfmp-QbbAZj-o7W1i4cjMwApqRoPO2XcNcwLtSilArlLcBBnYAoCm5ZUIMTBVZQgzcDrDbl4TZuDwhU54A5nQvFcswqDlCVk2rpCYBxpwKQbSKQqQC6CLFfLTFEqLUxVArbnU_DRRBkU31xBnD12gpfFwH8Y7-yHcZyzGwALs-adKMCgYmSYnJRkYWyZBTnk3TEoFNsiMjVPTTMwSk83NkyQZpHCbI4VPUpqBCxRaoMVUhoYyDCwlRaWpssDatSRJDhwsAGLQfRs
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMQSWeskGSQa6hskm5romxokpupap5ma6ySmmFmnmSYYGaeA7lnz9zDxCTbwiTCOYGLJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3bGQETKOGai5Otq4B_i7-zmrOzrbOfmp-QbbAZj-o7W1i4cjMwGoOOp0X1HQKcwLtSilArlLcBBnYAoCm5ZUIMTBVZQgzcDrDbl4TZuDwhU54A5nQvFcswqDlCVk2rpCYBxpwKQbSKQqQC6CLFfLTFEqLUxVArbnU_DRRBkU31xBnD12gpfFwH8Y7-yHcZyzGwALs-adKMCgYmSYnJRkYWyZBTnk3TEoFNsiMjVPTTMwSk83NkyQZpHCbI4VPUp6B0yPE1yfex9PPW5qBCxRyoIVVhoYyDCwlRaWpssCatiRJDhxEAGUEgAg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Insulin+analogs+and+methods+of+use+thereof&rft.inventor=VERDINO+PAOLO&rft.inventor=LEE%2C+STEPHEN%2C+L&rft.inventor=BERNARD%2C+MICHAEL%2C+J.%2C+SR&rft.date=2022-03-11&rft.externalDBID=A&rft.externalDocID=CN114174348A